Denis James Mintern - 23 Feb 2026 Form 4 Insider Report for CRH PUBLIC LTD CO (CRH)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
25 Feb 2026, 16:05:06 UTC
Prior SEC filing
15 May 2025
Next SEC filing
15 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Neil Colgan, Attorney-in-Fact for Denis James Mintern

Key filing fact

Denis James Mintern filed Form 4 for CRH PUBLIC LTD CO (CRH) on 25 Feb 2026.

Key facts

  • This page summarizes Denis James Mintern's Form 4 filing for CRH PUBLIC LTD CO (CRH).
  • 4 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 25 Feb 2026, 16:05.

Change

  • Previous filing in this sequence was filed on 15 May 2025.
  • Current net transaction value: -$906,120.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002013082 Primary reporting owner

Mintern Denis James

Relationship
Chief Executive Officer, Director
Address
C/O CRH PLC, STONEMASON'S WAY, RATHFARNHAM DUBLIN, IRELAND
Signature
/s/ Neil Colgan, Attorney-in-Fact for Denis James Mintern
Signature date
25 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CRH transaction

Ordinary Shares

Options Exercise

Transaction value
$0
Shares
+14,372
Change %
+40%
Price
$0.000000
Shares after
50,129
Date
23 Feb 2026
Ownership
Direct
Footnotes
F1
CRH transaction

Ordinary Shares

Tax liability

Transaction value
$906,120
Shares
-7,502
Change %
-15%
Price
$120.78
Shares after
42,627
Date
23 Feb 2026
Ownership
Direct
Footnotes
F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CRH transaction Derivative

Deferred Shares

Options Exercise

Transaction value
Shares
-13,389
Change %
-45%
Price
Shares after
16,271
Date
23 Feb 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
13,389
Exercise price
Footnotes
F1
CRH transaction Derivative

Restricted Share Units

Award

Transaction value
Shares
+41,281
Change %
+92%
Price
Shares after
86,236
Date
23 Feb 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
41,281
Exercise price
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Reflects the vesting and release of a time-based conditional award as defined in the 2014 Deferred Share Bonus Plan (the "DSB Plan Rules"), of which, pursuant to the determination of the Compensation Committee, a total of 14,372 shares vested on February 23, 2026, including the award of 983 additional Ordinary Shares as dividend equivalents.

Footnote F2

Mandatory sale of sufficient Ordinary Shares to cover applicable withholding tax liabilities arising in connection with the aforementioned awards.

Footnote F3

The reported price represents the volume-weighted average price of shares sold. Sale prices for the reported transaction ranged between $120.011 and $122.17, inclusive. Full information regarding the Ordinary Shares sold will be provided to the SEC upon request.

Footnote F4

Each restricted share unit ("RSU") represents the right to receive one Ordinary Share of the Issuer. Reflects a time-based conditional award, as defined in the CRH plc Equity Incentive Plan (the "EIP"), of RSUs of which 1/3 will vest on the grant anniversary in February 2027, 2028 and 2029, respectively (the "Awards"). In accordance with the EIP, dividend equivalents will apply to these Awards and will be reported at the time of vesting.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .